Beatriz Silva-Ramírez

6PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2025
Contribution of PNPLA3, GCKR, MBOAT7, NCAN, and TM6SF2 Genetic Variants to Hepatocellular Carcinoma Development in Mexican Patients.

Alejandro Arreola Cruz, Juan Carlos Navarro Hernández, Laura Estela Cisneros Garza

|Apr 23, 2025
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.

Beatriz Silva Ramírez, Katia Peñuelas Urquides, Brenda Leticia Escobedo Guajardo

|Feb 10, 2024
Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma.

Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll

|Apr 13, 2023
Sex, Age, and Comorbidities Are Associated with SARS-CoV-2 Infection, COVID-19 Severity, and Fatal Outcome in a Mexican Population: A Retrospective Multi-Hospital Study.

Maria Elena Camacho Moll, Viviana Leticia Mata Tijerina, Beatriz Silva Ramírez

|Oct 13, 2021
Isotretinoin and Thalidomide Down-Regulate c-MYC Gene Expression and Modify Proteins Associated with Cancer in Hepatic Cells.

Patricia Nefertari Ramírez-Flores, Paulina J Barraza-Reyna, Alain Aguirre-Vázquez

|Oct 02, 2021
Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men.

B Silva-Ramirez, E J Macías-González, O S Frausto-Valdes

Pageof 1

Frequent Collaborators

5 joint publications

Mario Bermúdez de León

2 joint publications

Viviana Leticia Mata Tijerina

2 joint publications

Brenda Leticia Escobedo Guajardo

2 joint publications

Katia Peñuelas-Urquides